Search results for:
gemtuzumab
gemtuzumab
- Restricted
- Restricted Mylotarg --> inpatient use restricted to newly diagnosed CD33 positive AML patients receiving combination therapy induction or consolidation treatment.
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Mylotarg |
POWDER FOR INJECTION, INTRAVENOUS |
5 mg |
|
|
|
|
Last updated: Jun. 28, 2022
Mylotarg restricted to oncology. Inpatient use restricted to newly diagnosed CD33 positive AML patients receiving combination therapy induction or consolidation treatment.
Reviewed: 24 April 2018, and 24 July 2018.